Hispanic adults with type 2 diabetes mellitus using lipid-lowering agents have better periodontal health than non-users.
Oelisoa M AndriankajaKaumudi J JoshipuraMichael A LevineMargarita Ramirez-VickJulio A Rivas-AgostoJorge S DucongeDana T GravesPublished in: Therapeutic advances in chronic disease (2023)
minimal LLA use. This association was not present among people using LLA > 4 years users, but these participants had poorer glycemic control compared to other participants. In this cross-sectional study, the finding that LLA use 1- 4 years is associated with lower values of periodontal parameters of severity in T2D individuals may help clarify some of the controversies regarding the benefit of these medications in this population.